Robert Negrin
Clinical Trials
- Bone Marrow Grafting for Leukemia and Lymphoma Recruiting
- Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation Recruiting
- Research Sample Repository for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation Recruiting
- A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft versus Host Disease Recruiting
- Allogeneic HCT using Nonmyeloablative Host Conditioning with TLI & ATG vs SOC in AML Recruiting
- Allogeneic Hematopoietic Cell Transplantation Using TLI/ATG for Older Patients with Hematologic Malignancies Recruiting
- Allogeneic Transplantation From Related Haploidentical Donors in Older Patients with Indolent Hematologic Malignancies Recruiting
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Recruiting
- Chronic GVHD Cohort Protocol Recruiting
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Recruiting
- Defibrotide for Hematopoietic SCT Patients With Severe Hepatic VOD: a Treatment IND Study Recruiting
- Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease Recruiting
- Imatinib Mesylate and Nilotinib After Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia Recruiting
- NMDP Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation Recruiting
- Ph II of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG Recruiting
- Ph II of Non-myeloablative Allgnc Trnsplnt Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma Recruiting
- Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous “Immunotransplant” for MCL Recruiting
- Phase II Poor Risk Diffuse Large B-cell Lymphoma (DLBCL) of Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) Followed by Matched Allogeneic Hematopoietic Transplantation as Consolidation to Autologous Hematopoietic Cell Transplantation (AHCT) Recruiting
- Sirolimus & Mycophenolate Mofetil as GVHD prophylaxis in Myeloablative, Matched Related Donor HCT Recruiting
- Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease Recruiting
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) Recruiting
- TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD Recruiting
- Enrichment & Purging of Stem Cells in Non-Hodgkin's Lymphoma No longer recruiting
- Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies No longer recruiting
- Transplantation for Patients with Chronic Lymphocytic Leukemia No longer recruiting
- A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Palifermin (rHuKGF) in the Reduction of Acute Graft Versus Host Disease in Subjects With Hematologic Malignancies Undergoing Allogeneic Marrow/PBPC Transplantation Completed
- Allo BMT in Advanced Leukemia or High Grade Lymphoma No longer recruiting
- Allogeneic Transplantation for Patients with Acute Leukemia or CML No longer recruiting
- Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission No longer recruiting
- Autologous Stem Cell Rescue for Primary Amyloidosis No longer recruiting
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease in Hematopoetic Stem Cell Transplant Patients No longer recruiting
- High -Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma No longer recruiting
- Mixed Chimera Allogeneic Transplantation From Matched Unrelated Donors For The Treatment Of Multiple Myeloma Completed
- Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders No longer recruiting
- Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies No longer recruiting
- Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients No longer recruiting
- Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors No longer recruiting
Help